These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 1182676)

  • 1. Evaluation of methotrexate in the treatment of bronchogenic carcinoma.
    Vincent RG; Pickren JW; Fergen TB; Takita H
    Cancer; 1975 Sep; 36(3):873-80. PubMed ID: 1182676
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Methotrexate compared with placebo in lung cancer.
    Selawry O; Krant M; Scotto J; Kazam E; Schneiderman M; Olson K; Shnider B; Edmonson J; Holland J; Taylor S
    Cancer; 1977 Jul; 40(1):4-8. PubMed ID: 880567
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemotherapy for bronchogenic carcinoma. Methotrexate, doxorubicin, cyclophosphamide, and lomustine.
    Chahinian PA; Arnold DJ; Cohen JM; Purpora DP; Jaffrey IS; Teirstein AS; Kirschner PA; Holland JF
    JAMA; 1977 May; 237(22):2392-6. PubMed ID: 576939
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combination chemotherapy with bleomycin (NSC-125066), vincristine (NSC-67574), and methotrexate (NSC-740) plus split-course radiotherapy in the treatment of non-oat-cell bronchogenic carcinoma.
    Samuels ML; Barkley HT; Holoye PY; Rosenberg PJ; Smith TL
    Cancer Chemother Rep; 1975; 59(2 Pt 1):377-83. PubMed ID: 50124
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bleomycin, cisplatin, vincristine, and methotrexate in advanced non-small cell bronchogenic carcinoma.
    Rosenthal CJ; Ritter S; Platica O
    Cancer Treat Rep; 1982 Jan; 66(1):205-6. PubMed ID: 6171350
    [No Abstract]   [Full Text] [Related]  

  • 6. [VP 16-213 in combination with endoxan, methotrexate and oncovin as polychemotherapy for bronchogenic carcinoma].
    Ryssel HJ; Hasler E; Sonntag RW; Cavalli F; Martin J; Tschopp L; Brunner KW
    Schweiz Med Wochenschr; 1977 Jul; 107(26):912-5. PubMed ID: 877537
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metastatic non-oat-cell bronchogenic carcinoma. Therapy with cyclophosphamide, doxorubicin, methotrexate, and procarbazine (CAMP).
    Bitran JD; Desser RK; DeMeester T; Golomb HM
    JAMA; 1978 Dec; 240(25):2743-6. PubMed ID: 713008
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Cytostatic therapy of tumors of the lung].
    De Marco F; Saviano G; Tenore G
    Arch Monaldi; 1974; 29(3-4):326-35. PubMed ID: 4463917
    [No Abstract]   [Full Text] [Related]  

  • 9. Treatment of bronchogenic carcinoma with simultaneous or sequential combination chemotherapy, including methotrexate, cyclophosphamide, procarbazine and vincristine.
    Alberto P; Brunner KW; Martz G; Obrecht J; Sonntag RW
    Cancer; 1976 Dec; 38(6):2208-16. PubMed ID: 187313
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cyclophosphamide, adriamycin, methotrexate, and procarbazine (CAMP)--effective four-drug combination chemotherapy for metastatic non-oat cell bronchogenic carcinoma.
    Bitran JD; Desser RK; DeMeester TR; Colman M; Evans R; Billings A; Griem M; Rubenstein L; Shapiro C; Golomb HM
    Cancer Treat Rep; 1976 Sep; 60(9):1225-30. PubMed ID: 189920
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CAMP chemotherapy for metastatic non-oat cell bronchogenic carcinoma. A 7-year experience (1975-1981) with 160 patients.
    Shepard KV; Golomb HM; Bitran JD; Hoffman PC; Newman SB; DeMeester TR; Skosey C
    Cancer; 1985 Nov; 56(10):2385-90. PubMed ID: 3876149
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Status report of adjuvant cancer chemotherapy trials in the treatment of bronchial carcinoma.
    Shields TW
    Cancer Chemother Rep 3; 1973 Mar; 4(2):119-24. PubMed ID: 4729315
    [No Abstract]   [Full Text] [Related]  

  • 13. Combination chemotherapy with CCNU (NSC-79037),hexamethylmelamine (NSC-13875) and methotrexate (NSC-740) in advanced bronchogenic carcinoma.
    DiBella NJ; Nelson RA; Norgard MJ
    Oncology; 1975; 32(2):82-5. PubMed ID: 815858
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bleomycin (NSC-125066) followed by cyclophosphamide (NSC-26271), vincristine (NSC-67574), methotrexate (NSC-740), and 5-fllorouracil (NSC-19893) for non-oat cell bronchogenic carcinoma.
    Lanzotti VJ; Thomas DR; Holoye PY; Boyle LE; Smith TL; Samuels ML
    Cancer Treat Rep; 1976 Jan; 60(1):61-8. PubMed ID: 63331
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Meningeal carcinomatosis: treatment with intrathecal methotrexate.
    Bender RA
    Oncology; 1974; 30(4):328-33. PubMed ID: 4480422
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Chemotherapy of the non-small cell bronchogenic carcinoma].
    Dimitriadis K; Boutis L; Tavantzis J; Mouratidou D; Bouchoris N; Koukourikos S; Hatzigogos K; Safarini S
    Onkologie; 1983 Feb; 6(1):8-10. PubMed ID: 6189039
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of the combination of hexamethylmelamine (NSC-13875) and methotrexate (NSC-740) in carcinoma of the lung.
    Weiss AJ; Wilson WL
    Cancer Chemother Rep; 1971 Jun; 55(3):299-302. PubMed ID: 5115850
    [No Abstract]   [Full Text] [Related]  

  • 18. Alkylating agents in bronchogenic carcinoma.
    Green RA; Humphrey E; Close H; Patno ME
    Am J Med; 1969 Apr; 46(4):516-25. PubMed ID: 5791000
    [No Abstract]   [Full Text] [Related]  

  • 19. [Prognostic factors in the chemotherapy of bronchial cancers].
    Alberto P
    Schweiz Med Wochenschr; 1974 Feb; 104(8):268-71. PubMed ID: 4360755
    [No Abstract]   [Full Text] [Related]  

  • 20. Methotrexate-related deaths in patients previously treated with cis-diamminedichloride platinum.
    Haim N; Kedar A; Robinson E
    Cancer Chemother Pharmacol; 1984; 13(3):223-5. PubMed ID: 6541532
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.